Pre-order Enquiry
Request Free Sample
Global Diagnostic Nuclear Medicines Market Insights, Forecast to 2025
SKU ID : QYR-14053937 | Publishing Date : 04-Apr-2019 | No. of pages : 115
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Diagnostic Nuclear Medicines Market Insights, Forecast to 2025
Table of Contents1 Study Coverage
1.1 Diagnostic Nuclear Medicines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Diagnostic Nuclear Medicines Market Size Growth Rate by Product
1.4.2 Tc-99m
1.4.3 F-18
1.4.4 Other
1.5 Market by End User
1.5.1 Global Diagnostic Nuclear Medicines Market Size Growth Rate by End User
1.5.2 Oncology
1.5.3 Cardiology
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Diagnostic Nuclear Medicines Market Size
2.1.1 Global Diagnostic Nuclear Medicines Revenue 2014-2025
2.1.2 Global Diagnostic Nuclear Medicines Sales 2014-2025
2.2 Diagnostic Nuclear Medicines Growth Rate by Regions
2.2.1 Global Diagnostic Nuclear Medicines Sales by Regions
2.2.2 Global Diagnostic Nuclear Medicines Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Diagnostic Nuclear Medicines Sales by Manufacturers
3.1.1 Diagnostic Nuclear Medicines Sales by Manufacturers
3.1.2 Diagnostic Nuclear Medicines Sales Market Share by Manufacturers
3.1.3 Global Diagnostic Nuclear Medicines Market Concentration Ratio (CR5 and HHI)
3.2 Diagnostic Nuclear Medicines Revenue by Manufacturers
3.2.1 Diagnostic Nuclear Medicines Revenue by Manufacturers (2014-2019)
3.2.2 Diagnostic Nuclear Medicines Revenue Share by Manufacturers (2014-2019)
3.3 Diagnostic Nuclear Medicines Price by Manufacturers
3.4 Diagnostic Nuclear Medicines Manufacturing Base Distribution, Product Types
3.4.1 Diagnostic Nuclear Medicines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Diagnostic Nuclear Medicines Product Type
3.4.3 Date of International Manufacturers Enter into Diagnostic Nuclear Medicines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Diagnostic Nuclear Medicines Sales by Product
4.2 Global Diagnostic Nuclear Medicines Revenue by Product
4.3 Diagnostic Nuclear Medicines Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Diagnostic Nuclear Medicines Breakdown Data by End User
6 North America
6.1 North America Diagnostic Nuclear Medicines by Countries
6.1.1 North America Diagnostic Nuclear Medicines Sales by Countries
6.1.2 North America Diagnostic Nuclear Medicines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Diagnostic Nuclear Medicines by Product
6.3 North America Diagnostic Nuclear Medicines by End User
7 Europe
7.1 Europe Diagnostic Nuclear Medicines by Countries
7.1.1 Europe Diagnostic Nuclear Medicines Sales by Countries
7.1.2 Europe Diagnostic Nuclear Medicines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Diagnostic Nuclear Medicines by Product
7.3 Europe Diagnostic Nuclear Medicines by End User
8 Asia Pacific
8.1 Asia Pacific Diagnostic Nuclear Medicines by Countries
8.1.1 Asia Pacific Diagnostic Nuclear Medicines Sales by Countries
8.1.2 Asia Pacific Diagnostic Nuclear Medicines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Diagnostic Nuclear Medicines by Product
8.3 Asia Pacific Diagnostic Nuclear Medicines by End User
9 Central & South America
9.1 Central & South America Diagnostic Nuclear Medicines by Countries
9.1.1 Central & South America Diagnostic Nuclear Medicines Sales by Countries
9.1.2 Central & South America Diagnostic Nuclear Medicines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Diagnostic Nuclear Medicines by Product
9.3 Central & South America Diagnostic Nuclear Medicines by End User
10 Middle East and Africa
10.1 Middle East and Africa Diagnostic Nuclear Medicines by Countries
10.1.1 Middle East and Africa Diagnostic Nuclear Medicines Sales by Countries
10.1.2 Middle East and Africa Diagnostic Nuclear Medicines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Diagnostic Nuclear Medicines by Product
10.3 Middle East and Africa Diagnostic Nuclear Medicines by End User
11 Company Profiles
11.1 Bracco Imaging
11.1.1 Bracco Imaging Company Details
11.1.2 Company Business Overview
11.1.3 Bracco Imaging Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Bracco Imaging Diagnostic Nuclear Medicines Products Offered
11.1.5 Bracco Imaging Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Company Business Overview
11.2.3 Bayer Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Bayer Diagnostic Nuclear Medicines Products Offered
11.2.5 Bayer Recent Development
11.3 Curium Pharmaceuticals
11.3.1 Curium Pharmaceuticals Company Details
11.3.2 Company Business Overview
11.3.3 Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Curium Pharmaceuticals Diagnostic Nuclear Medicines Products Offered
11.3.5 Curium Pharmaceuticals Recent Development
11.4 Nordion
11.4.1 Nordion Company Details
11.4.2 Company Business Overview
11.4.3 Nordion Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Nordion Diagnostic Nuclear Medicines Products Offered
11.4.5 Nordion Recent Development
11.5 Triad Isotopes
11.5.1 Triad Isotopes Company Details
11.5.2 Company Business Overview
11.5.3 Triad Isotopes Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Triad Isotopes Diagnostic Nuclear Medicines Products Offered
11.5.5 Triad Isotopes Recent Development
11.6 Lantheus
11.6.1 Lantheus Company Details
11.6.2 Company Business Overview
11.6.3 Lantheus Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Lantheus Diagnostic Nuclear Medicines Products Offered
11.6.5 Lantheus Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Details
11.7.2 Company Business Overview
11.7.3 GE Healthcare Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
11.7.4 GE Healthcare Diagnostic Nuclear Medicines Products Offered
11.7.5 GE Healthcare Recent Development
11.8 China Isotope & Radiation
11.8.1 China Isotope & Radiation Company Details
11.8.2 Company Business Overview
11.8.3 China Isotope & Radiation Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
11.8.4 China Isotope & Radiation Diagnostic Nuclear Medicines Products Offered
11.8.5 China Isotope & Radiation Recent Development
11.9 Jubilant Pharma
11.9.1 Jubilant Pharma Company Details
11.9.2 Company Business Overview
11.9.3 Jubilant Pharma Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Jubilant Pharma Diagnostic Nuclear Medicines Products Offered
11.9.5 Jubilant Pharma Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Company Business Overview
11.10.3 Eli Lilly Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Eli Lilly Diagnostic Nuclear Medicines Products Offered
11.10.5 Eli Lilly Recent Development
11.11 Novartis
11.12 SIEMENS
11.13 Dongcheng
11.14 Navidea
12 Future Forecast
12.1 Diagnostic Nuclear Medicines Market Forecast by Regions
12.1.1 Global Diagnostic Nuclear Medicines Sales Forecast by Regions 2019-2025
12.1.2 Global Diagnostic Nuclear Medicines Revenue Forecast by Regions 2019-2025
12.2 Diagnostic Nuclear Medicines Market Forecast by Product
12.2.1 Global Diagnostic Nuclear Medicines Sales Forecast by Product 2019-2025
12.2.2 Global Diagnostic Nuclear Medicines Revenue Forecast by Product 2019-2025
12.3 Diagnostic Nuclear Medicines Market Forecast by End User
12.4 North America Diagnostic Nuclear Medicines Forecast
12.5 Europe Diagnostic Nuclear Medicines Forecast
12.6 Asia Pacific Diagnostic Nuclear Medicines Forecast
12.7 Central & South America Diagnostic Nuclear Medicines Forecast
12.8 Middle East and Africa Diagnostic Nuclear Medicines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Diagnostic Nuclear Medicines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global Diagnostic Nuclear Medicines Market Insights, Forecast to 2025
List of Tables and FiguresFigure Diagnostic Nuclear Medicines Product Picture
Table Diagnostic Nuclear Medicines Market Segments
Table Key Manufacturers Diagnostic Nuclear Medicines Covered
Table Global Diagnostic Nuclear Medicines Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Diagnostic Nuclear Medicines Sales Market Share by Product 2014-2025
Figure Tc-99m Product Picture
Table Major Manufacturers of Tc-99m
Figure F-18 Product Picture
Table Major Manufacturers of F-18
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Diagnostic Nuclear Medicines Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Oncology
Figure Cardiology
Figure Other
Figure Diagnostic Nuclear Medicines Report Years Considered
Figure Global Diagnostic Nuclear Medicines Market Size 2014-2025 (Million US$)
Figure Global Diagnostic Nuclear Medicines Sales 2014-2025 (K Units)
Table Global Diagnostic Nuclear Medicines Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Diagnostic Nuclear Medicines Sales by Regions 2014-2019 (K Units)
Table Global Diagnostic Nuclear Medicines Sales Market Share by Regions 2014-2019
Figure Global Diagnostic Nuclear Medicines Sales Market Share by Regions 2014-2019
Figure 2018 Global Diagnostic Nuclear Medicines Sales Market Share by Regions
Table Global Diagnostic Nuclear Medicines Revenue by Regions 2014-2019 (Million US$)
Table Global Diagnostic Nuclear Medicines Revenue Market Share by Regions 2014-2019
Figure Global Diagnostic Nuclear Medicines Revenue Market Share by Regions 2014-2019
Figure 2018 Global Diagnostic Nuclear Medicines Revenue Market Share by Regions
Table Global Diagnostic Nuclear Medicines Sales by Manufacturers (2014-2019) (K Units)
Table Global Diagnostic Nuclear Medicines Sales Share by Manufacturers (2014-2019)
Figure Global Diagnostic Nuclear Medicines Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Diagnostic Nuclear Medicines Revenue by Manufacturers (2014-2019) (Million USD)
Table Diagnostic Nuclear Medicines Revenue Share by Manufacturers (2014-2019)
Figure Diagnostic Nuclear Medicines Value Share by Manufacturers in 2018
Table Key Manufacturers Diagnostic Nuclear Medicines Price (2014-2019) (USD/Unit)
Table Diagnostic Nuclear Medicines Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Diagnostic Nuclear Medicines Product Type
Table Date of International Manufacturers Enter into Diagnostic Nuclear Medicines Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Diagnostic Nuclear Medicines Sales by Product (2014-2019) (K Units)
Table Global Diagnostic Nuclear Medicines Sales Share by Product (2014-2019)
Figure Global Diagnostic Nuclear Medicines Sales Market Share by Product (2014-2019)
Figure Global Diagnostic Nuclear Medicines Sales Market Share by Product in 2018
Table Global Diagnostic Nuclear Medicines Revenue by Product (2014-2019) (Million US$)
Table Global Diagnostic Nuclear Medicines Revenue Share by Product (2014-2019)
Figure Global Diagnostic Nuclear Medicines Revenue Market Share by Product (2014-2019)
Figure Global Diagnostic Nuclear Medicines Revenue Market Share by Product in 2018
Table Diagnostic Nuclear Medicines Price by Product 2014-2019 (USD/Unit)
Table Global Diagnostic Nuclear Medicines Sales by End User (2014-2019) (K Units)
Table Global Diagnostic Nuclear Medicines Sales Share by End User (2014-2019)
Figure Global Sales Diagnostic Nuclear Medicines Market Share by End User (2014-2019)
Figure Global Sales Diagnostic Nuclear Medicines Market Share by End User in 2018
Figure North America Diagnostic Nuclear Medicines Sales Growth Rate 2014-2019 (K Units)
Figure North America Diagnostic Nuclear Medicines Revenue Growth Rate 2014-2019 (Million US$)
Table North America Diagnostic Nuclear Medicines Sales by Countries (2014-2019) (K Units)
Table North America Diagnostic Nuclear Medicines Sales Market Share by Countries (2014-2019)
Figure 2018 North America Diagnostic Nuclear Medicines Sales Market Share by Countries
Table North America Diagnostic Nuclear Medicines Revenue by Countries (2014-2019) (Million US$)
Table North America Diagnostic Nuclear Medicines Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Diagnostic Nuclear Medicines Revenue Market Share by Countries
Figure United States Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure United States Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure Canada Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Table North America Diagnostic Nuclear Medicines Sales by Product (2014-2019) (K Units)
Table North America Diagnostic Nuclear Medicines Sales Market Share by Product (2014-2019)
Figure 2018 North America Diagnostic Nuclear Medicines Market Share by Product
Table North America Diagnostic Nuclear Medicines Sales by End User (2014-2019) (K Units)
Table North America Diagnostic Nuclear Medicines Sales Market Share by End User (2014-2019)
Figure 2018 North America Diagnostic Nuclear Medicines Market Share by End User
Figure Europe Diagnostic Nuclear Medicines Sales Growth Rate 2014-2019 (K Units)
Figure Europe Diagnostic Nuclear Medicines Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Diagnostic Nuclear Medicines Sales by Countries (2014-2019) (K Units)
Table Europe Diagnostic Nuclear Medicines Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Diagnostic Nuclear Medicines Sales Market Share by Countries
Table Europe Diagnostic Nuclear Medicines Revenue by Countries (2014-2019) (Million US$)
Table Europe Diagnostic Nuclear Medicines Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Diagnostic Nuclear Medicines Revenue Market Share by Countries
Figure Germany Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure Germany Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Figure France Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure France Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure UK Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure Italy Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure Russia Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Diagnostic Nuclear Medicines Sales by Product (2014-2019) (K Units)
Table Europe Diagnostic Nuclear Medicines Sales Market Share by Product (2014-2019)
Figure 2018 Europe Diagnostic Nuclear Medicines Market Share by Product
Table Europe Diagnostic Nuclear Medicines Sales by End User (2014-2019) (K Units)
Table Europe Diagnostic Nuclear Medicines Sales Market Share by End User (2014-2019)
Figure 2018 Europe Diagnostic Nuclear Medicines Market Share by End User
Figure Asia Pacific Diagnostic Nuclear Medicines Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Diagnostic Nuclear Medicines Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Diagnostic Nuclear Medicines Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Diagnostic Nuclear Medicines Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Diagnostic Nuclear Medicines Sales Market Share by Countries
Table Asia Pacific Diagnostic Nuclear Medicines Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Diagnostic Nuclear Medicines Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Diagnostic Nuclear Medicines Revenue Market Share by Countries
Figure China Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure China Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure Japan Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure Korea Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Figure India Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure India Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure Australia Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Diagnostic Nuclear Medicines Sales by Product (2014-2019) (K Units)
Table Asia Pacific Diagnostic Nuclear Medicines Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Diagnostic Nuclear Medicines Market Share by Product
Table Asia Pacific Diagnostic Nuclear Medicines Sales by End User (2014-2019) (K Units)
Table Asia Pacific Diagnostic Nuclear Medicines Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Diagnostic Nuclear Medicines Market Share by End User
Figure Central & South America Diagnostic Nuclear Medicines Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Diagnostic Nuclear Medicines Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Diagnostic Nuclear Medicines Sales by Countries (2014-2019) (K Units)
Table Central & South America Diagnostic Nuclear Medicines Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Diagnostic Nuclear Medicines Sales Market Share by Countries
Table Central & South America Diagnostic Nuclear Medicines Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Diagnostic Nuclear Medicines Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Diagnostic Nuclear Medicines Revenue Market Share by Countries
Figure Brazil Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Diagnostic Nuclear Medicines Sales by Product (2014-2019) (K Units)
Table Central & South America Diagnostic Nuclear Medicines Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Diagnostic Nuclear Medicines Market Share by Product
Table Central & South America Diagnostic Nuclear Medicines Sales by End User (2014-2019) (K Units)
Table Central & South America Diagnostic Nuclear Medicines Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Diagnostic Nuclear Medicines Market Share by End User
Figure Middle East and Africa Diagnostic Nuclear Medicines Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Diagnostic Nuclear Medicines Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Diagnostic Nuclear Medicines Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Diagnostic Nuclear Medicines Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Diagnostic Nuclear Medicines Sales Market Share by Countries
Table Middle East and Africa Diagnostic Nuclear Medicines Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Diagnostic Nuclear Medicines Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Diagnostic Nuclear Medicines Revenue Market Share by Countries
Figure GCC Countries Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Diagnostic Nuclear Medicines Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Diagnostic Nuclear Medicines Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Diagnostic Nuclear Medicines Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Diagnostic Nuclear Medicines Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Diagnostic Nuclear Medicines Market Share by Product
Table Middle East and Africa Diagnostic Nuclear Medicines Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Diagnostic Nuclear Medicines Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Diagnostic Nuclear Medicines Market Share by End User
Table Bracco Imaging Company Details
Table Bracco Imaging Diagnostic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bracco Imaging Recent Development
Table Bayer Company Details
Table Bayer Diagnostic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Recent Development
Table Curium Pharmaceuticals Company Details
Table Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Curium Pharmaceuticals Recent Development
Table Nordion Company Details
Table Nordion Diagnostic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Nordion Recent Development
Table Triad Isotopes Company Details
Table Triad Isotopes Diagnostic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Triad Isotopes Recent Development
Table Lantheus Company Details
Table Lantheus Diagnostic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Lantheus Recent Development
Table GE Healthcare Company Details
Table GE Healthcare Diagnostic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GE Healthcare Recent Development
Table China Isotope & Radiation Company Details
Table China Isotope & Radiation Diagnostic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table China Isotope & Radiation Recent Development
Table Jubilant Pharma Company Details
Table Jubilant Pharma Diagnostic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Jubilant Pharma Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Diagnostic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly Recent Development
Table Novartis Company Details
Table SIEMENS Company Details
Table Dongcheng Company Details
Table Navidea Company Details
Table Global Diagnostic Nuclear Medicines Sales Forecast by Regions 2019-2025 (K Units)
Table Global Diagnostic Nuclear Medicines Sales Market Share Forecast by Regions 2019-2025
Table Global Diagnostic Nuclear Medicines Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Diagnostic Nuclear Medicines Revenue Market Share Forecast by Regions 2019-2025
Table Global Diagnostic Nuclear Medicines Sales Forecast by Product 2019-2025 (K Units)
Table Global Diagnostic Nuclear Medicines Sales Market Share Forecast by Product 2019-2025
Table Global Diagnostic Nuclear Medicines Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Diagnostic Nuclear Medicines Revenue Market Share Forecast by Product 2019-2025
Table Global Diagnostic Nuclear Medicines Sales Forecast by End User 2019-2025 (K Units)
Table Global Diagnostic Nuclear Medicines Sales Market Share Forecast by End User 2019-2025
Figure North America Diagnostic Nuclear Medicines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Diagnostic Nuclear Medicines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Diagnostic Nuclear Medicines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Diagnostic Nuclear Medicines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Diagnostic Nuclear Medicines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Diagnostic Nuclear Medicines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Diagnostic Nuclear Medicines Value Chain
Table Diagnostic Nuclear Medicines Customers List
Table Diagnostic Nuclear Medicines Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Keyplayers in Global Diagnostic Nuclear Medicines Market Insights, Forecast to 2025
Bracco ImagingBayer
Curium Pharmaceuticals
Nordion
Triad Isotopes
Lantheus
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Novartis
SIEMENS
Dongcheng
Navidea
